CN Patent

CN116997330A — 具有低水平氨基甲酸盐的透皮安非他命组合物

Assigned to Noven Pharmaceuticals Inc · Expires 2023-11-03 · 3y expired

What this patent protects

描述了用于在透皮安非他命组合物中减少安非他命氨基甲酸盐(amphetamine carbamate)和安非他命甲酸根(amphetacarbamate)的形成的方法，具有低水平安非他命甲酸根的组合物以及使用这种组合物用于安非他命透皮递送的方法。

USPTO Abstract

描述了用于在透皮安非他命组合物中减少安非他命氨基甲酸盐(amphetamine carbamate)和安非他命甲酸根(amphetacarbamate)的形成的方法，具有低水平安非他命甲酸根的组合物以及使用这种组合物用于安非他命透皮递送的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN116997330A
Jurisdiction
CN
Classification
—
Expires
2023-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Noven Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.